# State Street Corp: financial statements, quarterly

STT · NYSE · CIK 93751 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/stt.md) · [Financials](/companies/stt/financials.md) · [Filings](/companies/stt/filings.md) · [Insiders](/companies/stt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/stt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,691](/filings/0000093751-24-000909.md) | [3,043 d](/filings/0000093751-26-000124.md) | [3,138](/filings/0000093751-25-000226.md) | [3,191](/filings/0000093751-25-000425.md) | [3,259](/filings/0000093751-25-000575.md) | [3,412 d](/filings/0000093751-26-000124.md) | [3,284](/filings/0000093751-26-000196.md) | [3,448](/filings/0000093751-26-000397.md) | [3,545](/filings/0000093751-25-000575.md) | [3,667 d](/filings/0000093751-26-000124.md) | [3,796](/filings/0000093751-26-000196.md) | [4,048](/filings/0000093751-26-000397.md) |
| Interest expense | $m | [1,704](/filings/0000093751-23-000694.md) | [1,915 d](/filings/0000093751-24-000498.md) | [2,173](/filings/0000093751-24-000587.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [89.0](/filings/0000093751-24-000909.md) | [(9.0) d](/filings/0000093751-26-000124.md) | [135](/filings/0000093751-25-000226.md) | [201](/filings/0000093751-25-000425.md) | [195](/filings/0000093751-25-000575.md) | [177 d](/filings/0000093751-26-000124.md) | [178](/filings/0000093751-26-000196.md) | [196](/filings/0000093751-26-000397.md) | [241](/filings/0000093751-25-000575.md) | [171 d](/filings/0000093751-26-000124.md) | [205](/filings/0000093751-26-000196.md) | [305](/filings/0000093751-26-000397.md) |
| Net income | $m | [422](/filings/0000093751-24-000909.md) | [210 d](/filings/0000093751-26-000124.md) | [463](/filings/0000093751-25-000575.md) | [711](/filings/0000093751-25-000575.md) | [730](/filings/0000093751-25-000575.md) | [783 d](/filings/0000093751-26-000124.md) | [644](/filings/0000093751-26-000397.md) | [693](/filings/0000093751-26-000397.md) | [861](/filings/0000093751-25-000575.md) | [747 d](/filings/0000093751-26-000124.md) | [764](/filings/0000093751-26-000397.md) | [1,084](/filings/0000093751-26-000397.md) |
| Diluted EPS | $ per share | [1.25](/filings/0000093751-24-000909.md) | not reported | [1.37](/filings/0000093751-25-000226.md) | [2.15](/filings/0000093751-25-000425.md) | [2.26](/filings/0000093751-25-000575.md) | not reported | [2.04](/filings/0000093751-26-000196.md) | [2.17](/filings/0000093751-26-000397.md) | [2.78](/filings/0000093751-25-000575.md) | not reported | [2.49](/filings/0000093751-26-000196.md) | [3.65](/filings/0000093751-26-000397.md) |
| Basic EPS | $ per share | [1.27](/filings/0000093751-24-000909.md) | not reported | [1.38](/filings/0000093751-25-000226.md) | [2.18](/filings/0000093751-25-000425.md) | [2.29](/filings/0000093751-25-000575.md) | not reported | [2.07](/filings/0000093751-26-000196.md) | [2.20](/filings/0000093751-26-000397.md) | [2.83](/filings/0000093751-25-000575.md) | not reported | [2.53](/filings/0000093751-26-000196.md) | [3.71](/filings/0000093751-26-000397.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $bn | [284](/filings/0000093751-23-000694.md) | [297](/filings/0000093751-25-000111.md) | [338](/filings/0000093751-24-000587.md) | [326](/filings/0000093751-24-000665.md) | [338](/filings/0000093751-24-000909.md) | [353](/filings/0000093751-26-000124.md) | [373](/filings/0000093751-25-000226.md) | [377](/filings/0000093751-25-000425.md) | [371](/filings/0000093751-25-000575.md) | [366](/filings/0000093751-26-000397.md) | [392](/filings/0000093751-26-000196.md) | [418](/filings/0000093751-26-000397.md) |
| Total liabilities | $bn | [261](/filings/0000093751-23-000694.md) | [273](/filings/0000093751-25-000111.md) | [314](/filings/0000093751-24-000587.md) | [301](/filings/0000093751-24-000665.md) | [313](/filings/0000093751-24-000909.md) | [328](/filings/0000093751-26-000124.md) | [346](/filings/0000093751-25-000226.md) | [349](/filings/0000093751-25-000425.md) | [343](/filings/0000093751-25-000575.md) | [338](/filings/0000093751-26-000397.md) | [364](/filings/0000093751-26-000196.md) | [390](/filings/0000093751-26-000397.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [23.6](/filings/0000093751-24-000909.md) | [23.8](/filings/0000093751-26-000124.md) | [24.4](/filings/0000093751-25-000575.md) | [24.8](/filings/0000093751-25-000575.md) | [25.8](/filings/0000093751-25-000575.md) | [25.3](/filings/0000093751-26-000397.md) | [26.7](/filings/0000093751-26-000397.md) | [27.3](/filings/0000093751-26-000397.md) | [27.6](/filings/0000093751-25-000575.md) | [27.8](/filings/0000093751-26-000397.md) | [27.7](/filings/0000093751-26-000397.md) | [28.3](/filings/0000093751-26-000397.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $bn | [0.2 d](/filings/0000093751-24-000909.md) | [4.2 d](/filings/0000093751-26-000124.md) | [(0.8)](/filings/0000093751-25-000226.md) | [(7.6) d](/filings/0000093751-25-000425.md) | [2.7 d](/filings/0000093751-25-000575.md) | [(7.4) d](/filings/0000093751-26-000124.md) | [2.4](/filings/0000093751-26-000196.md) | [(8.4) d](/filings/0000093751-26-000397.md) | [7.9 d](/filings/0000093751-25-000575.md) | [10.0 d](/filings/0000093751-26-000124.md) | [(12.1)](/filings/0000093751-26-000196.md) | [(2.3) d](/filings/0000093751-26-000397.md) |
| Capital expenditure | $bn | [0.1 d](/filings/0000093751-24-000909.md) | [0.3 d](/filings/0000093751-26-000124.md) | [0.2](/filings/0000093751-25-000226.md) | [0.2 d](/filings/0000093751-25-000425.md) | [0.2 d](/filings/0000093751-25-000575.md) | [0.2 d](/filings/0000093751-26-000124.md) | [0.2](/filings/0000093751-26-000196.md) | [0.3 d](/filings/0000093751-26-000397.md) | [0.2 d](/filings/0000093751-25-000575.md) | [0.3 d](/filings/0000093751-26-000124.md) | [0.3](/filings/0000093751-26-000196.md) | [0.7 d](/filings/0000093751-26-000397.md) |
| Dividends paid | $bn | [0.2 d](/filings/0000093751-24-000909.md) | [0.3 d](/filings/0000093751-26-000124.md) | [0.2](/filings/0000093751-25-000226.md) | [0.3 d](/filings/0000093751-25-000425.md) | [0.2 d](/filings/0000093751-25-000575.md) | [0.3 d](/filings/0000093751-26-000124.md) | [0.3](/filings/0000093751-26-000196.md) | [0.3 d](/filings/0000093751-26-000397.md) | [0.3 d](/filings/0000093751-25-000575.md) | [0.3 d](/filings/0000093751-26-000124.md) | [0.3](/filings/0000093751-26-000196.md) | [0.3 d](/filings/0000093751-26-000397.md) |
| Share repurchases | $bn | [1.0 d](/filings/0000093751-24-000909.md) | [0.5 d](/filings/0000093751-26-000124.md) | [0.1](/filings/0000093751-25-000226.md) | [0.2 d](/filings/0000093751-25-000425.md) | [0.5 d](/filings/0000093751-25-000575.md) | [0.6 d](/filings/0000093751-26-000124.md) | [0.1](/filings/0000093751-26-000196.md) | [0.3 d](/filings/0000093751-26-000397.md) | [0.4 d](/filings/0000093751-25-000575.md) | [0.4 d](/filings/0000093751-26-000124.md) | [0.4](/filings/0000093751-26-000196.md) | [0.4 d](/filings/0000093751-26-000397.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [372](/filings/0000093751-23-000694.md) | [345](/filings/0000093751-24-000587.md) | [334](/filings/0000093751-24-000665.md) | [317](/filings/0000093751-24-000909.md) | [306](/filings/0000093751-25-000226.md) | [305](/filings/0000093751-25-000425.md) | [302](/filings/0000093751-25-000575.md) | [293](/filings/0000093751-26-000196.md) | [290](/filings/0000093751-26-000397.md) | [288](/filings/0000093751-25-000575.md) | [283](/filings/0000093751-26-000196.md) | [281](/filings/0000093751-26-000397.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 274,701,765 at 2026-07-28, from the cover of the [10-Q filed 2026-07-30](/filings/0000093751-26-000397.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.